News for 'Sun Pharmaceuticals'

IPO Boom Fuel Investment Bankers' Fortunes

IPO Boom Fuel Investment Bankers' Fortunes

Rediff.com21 Aug 2024

So far this year, bankers have earned Rs 1,226 crore for handling 45 IPOs, which together mobilised Rs 48,363 crore.

Will Modi Achieve A Cease Fire In Ukraine?

Will Modi Achieve A Cease Fire In Ukraine?

Rediff.com21 Aug 2024

Ukraine is currently in the middle of a strategic offensive into Russia's Kursk region.

Israel conflict unlikely to impact trade of pharma firms

Israel conflict unlikely to impact trade of pharma firms

Rediff.com12 Oct 2023

Indian pharmaceutical firms foresee minimal disruptions in trade with Israel despite escalating regional tensions. Rising crude prices and export shipping insurance premiums have raised concerns, but the pharmaceutical sector remains optimistic. Pharmaceutical exports from India to Israel in FY 2020-21 amounted to $32.5 million, which represents only a minor segment of India's overall pharma exports.

185 Indians In $1 Billion Club

185 Indians In $1 Billion Club

Rediff.com3 Sep 2024

The combined wealth of India's dollar billionaires is now equivalent to 33.81 per cent of India's nominal GDP.

MNCs look towards India for a booster dose

MNCs look towards India for a booster dose

Rediff.com1 Apr 2024

In recent months, several pharma multinational corporations (MNCs) are increasingly turning to Indian companies to expand market reach in the country's pharmaceuticals sector. Sanofi's partnerships with Dr Reddy's, Cipla, and Emcure, AstraZeneca and Mankind Pharma - teaming up for asthma medication distribution - are a few instances of this trend. This strategy allows MNCs to leverage established Indian networks and reach a wider audience. Indian companies also benefit from global brands and expertise, say analysts.

AstraZeneca reaffirms Covid vaccine safety amid rare TTS concerns

AstraZeneca reaffirms Covid vaccine safety amid rare TTS concerns

Rediff.com1 May 2024

Despite these rare occurrences, the pharmaceutical company maintains that extensive clinical trial data and real-world evidence consistently support the vaccine's safety and efficacy.

Promoter dilution in small, midcaps surges

Promoter dilution in small, midcaps surges

Rediff.com4 Oct 2024

The controlling shareholders of smaller and mid-sized companies are reducing their stakes at levels seldom seen since the 2008 global financial crisis. Over 20 per cent of companies listed on BSE MidCap and BSE SmallCap have seen a decline in promoter holdings for five consecutive quarters, reveals data from DSP Mutual Fund, shared with Business Standard. In the latest June quarter, the figure stood at 22.6 per cent.

Pharma cos okay with QR codes to combat counterfeit drugs

Pharma cos okay with QR codes to combat counterfeit drugs

Rediff.com19 Jul 2024

As the Drugs Controller General of India (DCGI) is set to crack down on companies to ensure compliance with printing QR codes on top-selling brands to curb counterfeiting, top pharma companies say they welcome the regulator's mandate and that they are on track. They also view it as a positive step to ensure patient safety. Sheetal Arora, CEO of Mankind Pharmaceuticals, which has already adopted QR codes in 20 of their products, stated: "We strongly advocate for mandatory implementation of barcodes and QR codes on medicines as this initiative will not only protect patients but also strengthen the integrity of our healthcare system by reducing circulation of counterfeit drugs."

Stock markets rise on gains in Tata Motors, HDFC Bank

Stock markets rise on gains in Tata Motors, HDFC Bank

Rediff.com30 Jul 2024

From the Sensex pack, Tata Motors, NTPC, Bajaj Finserv, Power Grid Corp, Titan, Asian Paints, IndusInd Bank, Maruti Suzuki India and Tata Steel were among the biggest gainers. Sun Pharmaceuticals, ITC, Hindustan Unilever, Bharti Airtel, UltraTech Cement and Reliance Industries were among the laggards.

Why Is Maharashtra An Underperformer?

Why Is Maharashtra An Underperformer?

Rediff.com23 Nov 2024

'Why has Maharashtra slipped up over the past couple of decades?' 'Not only is this question critical for residents of the state, but given that it accounts for 14% of India's GDP, a faster-growing Maharashtra implies a faster-growing India as well, point out Shishir Gupta and Rishita Sachdeva.

Sensex, Nifty hit fresh lifetime highs on gains in ICICI Bank, Infosys shares

Sensex, Nifty hit fresh lifetime highs on gains in ICICI Bank, Infosys shares

Rediff.com4 Jul 2024

Among the Sensex pack, HCL Technologies, ICICI Bank, Tata Motors, Sun Pharmaceuticals, Tata Consultancy Services, Infosys, Kotak Mahindra Bank and Mahindra and Mahindra were the gainers. In contrast, HDFC Bank, Bajaj Finance, Larsen & Toubro, Tech Mahindra, UltraTech Cement and IndusInd Bank were among the laggards.

With Rs 11.6 lakh cr wealth, Adani replaces Ambani as India's richest

With Rs 11.6 lakh cr wealth, Adani replaces Ambani as India's richest

Rediff.com29 Aug 2024

Recouping the dent caused by the Hindenburg Research report, Gautam Adani's networth shot up 95 per cent to Rs 11.6 lakh crore last year, which helped him replace Mukesh Ambani to become the richest Indian, a report said on Thursday. Reliance Industries chairman and managing director Ambani's overall networth increased by 25 per cent to Rs 10.14 lakh crore, as per the 2024 Hurun India Rich List. In 2023's report, Adani's wealth declined by 57 per cent to Rs 4.74 lakh crore, and Ambani was way ahead with a fortune of Rs 8.08 lakh crore.

Sensex slips below 80K; Nifty scales new high

Sensex slips below 80K; Nifty scales new high

Rediff.com5 Jul 2024

Among the 30-share Sensex pack, State Bank of India, Reliance Industries, Hindustan Unilever, NTPC, Larsen & Toubro, Nestle India, Power Grid, ITC, JSW Steel and Sun Pharmaceuticals were the major gainers. On the other hand, HDFC Bank, Titan, Mahindra & Mahindra, IndusInd Bank, UltraTech Cement, Tata Motors, HCL Technologies and Asian Paints were among the laggards.

No timeline on Ukraine war, says Putin; appreciates Modi

No timeline on Ukraine war, says Putin; appreciates Modi

Rediff.com19 Oct 2024

Putin said that the Indian leader had "aptly" noted that it is "not an anti-western one but a non-western one".

Putin invites Palestine Prez Abbas to BRICS summit; Modi to attend

Putin invites Palestine Prez Abbas to BRICS summit; Modi to attend

Rediff.com19 Oct 2024

Putin expressed concern over the situation in Gaza, and said Palestinian President Mahmoud Abbas has been invited to BRICS events.

Sensex, Nifty rise on buying in banking stocks

Sensex, Nifty rise on buying in banking stocks

Rediff.com10 Oct 2024

Equity benchmark indices Sensex and Nifty settled higher on Thursday, powered by a rally in banking and power stocks amid a largely firm trend in global markets. The stock markets mostly traded range-bound in the absence of any major trigger and persistent foreign capital outflows, traders said. The 30-share BSE Sensex rose 144.31 points, or 0.18 per cent, to settle at 81,611.41.

GST Gamed For Rs 81,875 cr, Finds Report

GST Gamed For Rs 81,875 cr, Finds Report

Rediff.com16 Sep 2024

The highest-ever goods and services tax (GST) evasion has been done by the online money gaming industry.

Zelenskyy explains war situation, Modi says India willing to help

Zelenskyy explains war situation, Modi says India willing to help

Rediff.com24 Aug 2024

Ukraine and Russia need to engage with each other to find a solution to the ongoing conflict between them, India said on Friday after Prime Minister Narendra Modi held wide-ranging talks with President Volodymyr Zelenskyy in Kyiv under the shadow of the raging war.

17 persons killed, 33 hurt in Andhra pharma unit fire

17 persons killed, 33 hurt in Andhra pharma unit fire

Rediff.com22 Aug 2024

Harrowing scenes unfolded at the SEZ where the fire ripped through the pharma company. Injured workers with torn clothes and bleeding injuries were seen being shifted to hospitals in ambulances.

'Nifty Pullback Needs To Be Taken In Stride'

'Nifty Pullback Needs To Be Taken In Stride'

Rediff.com22 Oct 2024

'The biggest near-term risk to Indian equities is the outflow of investments to China as tactical trades by foreign investors.'

Subhash Dandekar: The man who brought colours to artists and students!

Subhash Dandekar: The man who brought colours to artists and students!

Rediff.com17 Jul 2024

Subhash Dandekar, chairman emeritus of Kokuyo Camlin and the man known for bringing colours to artists as well as students in the country, passed away on Monday at 85.

'Ladakh Made The World Wary Of China'

'Ladakh Made The World Wary Of China'

Rediff.com7 Nov 2024

'While my generation carries with it the memory of the Chinese perfidy of 1962, this generation will carry the memory of Chinese perfidy in Galwan.'

Modiji Blesses Anant-Radhika

Modiji Blesses Anant-Radhika

Rediff.com14 Jul 2024

Prime Minister Narendra D Modi on Saturday blessed the newly wed couple Anant Ambani and Radhika Merchant after their wedding that was attended by global celebrities, business tycoons and politicians.

India To Fast-Track Visas For Chinese Nationals

India To Fast-Track Visas For Chinese Nationals

Rediff.com8 Aug 2024

The new guidelines, effective from August 1, aim to expedite visa approvals for nationals from China and other countries sharing land borders with India.

Listed firms log record operating cash flow of Rs 11.1 trn in FY24

Listed firms log record operating cash flow of Rs 11.1 trn in FY24

Rediff.com2 Oct 2024

Indian companies are generating more cash than ever. The net cash flow from listed firms' operations hit a new high of Rs 11.1 trillion in financial year 2023-24 (FY24), crossing the Rs 10-trillion mark for the first time, according to the Centre for Monitoring Indian Economy (CMIE) data going back to 1990-91. The FY24 figure represents a 19.3 per cent jump over the previous year, even as quite a few companies are yet to release their numbers.

High-level delegation of US pension funds to visit India next week

High-level delegation of US pension funds to visit India next week

Rediff.com6 Sep 2024

A delegation of high-level executives from US public pension funds (non-profit and government sectors) is visiting India next week to assess and familiarise themselves with the investment opportunities in the country. These executives belong to various American states and cumulatively represent $1.8 trillion in assets under management (AUM) invested across the US and global markets. The United States (US) mission to India, which includes its embassy and consulates and the Department of Treasury, along with India's Ministry of Finance and the National Investment and Infrastructure Fund (NIIF), is hosting the delegation.

Markets Expected To Remain Volatile

Markets Expected To Remain Volatile

Rediff.com4 Oct 2024

'As the markets are expected to remain jittery in the near term, we advise investors to use this opportunity to enter quality largecaps from a long-term perspective.'

AI Disruption Is REAL & Happening FAST!

AI Disruption Is REAL & Happening FAST!

Rediff.com28 Aug 2024

When AI is used to enhance operational efficiency, businesses can deliver the same product or service but with improved quality, faster, or even at a reduced cost

Is A Toxic Work Culture Affecting You?

Is A Toxic Work Culture Affecting You?

Rediff.com20 Sep 2024

"There is a limit when it comes to tolerating abusive behaviour or working styles. Many (employees) find ways to quit," says career coach and rediffGURU Pradeep Pramanik.

Govt cuts customs duty on 3 cancer drugs

Govt cuts customs duty on 3 cancer drugs

Rediff.com23 Jul 2024

The government proposes to cut custom duties on Trastuzumab Deruxtecan, Osimertinib and Durvalumab from 10 per cent to nil.

Emami has built itself through acquisition, but...

Emami has built itself through acquisition, but...

Rediff.com8 Oct 2024

Two young men jostle in a rickshaw as it clatters along a narrow, bustling lane of North Kolkata, each with a leg dangling over the side of the vehicle, a bulging sack of cosmetics nestled between them. The protagonists here are the founders of Emami - Radhe Shyam Agarwal and Radhe Shyam Goenka - childhood friends who gave up cushy corporate jobs to build a fast-moving consumer goods (FMCG) company. From a 200-square-foot rented space on Muktaram Babu Street in North Kolkata, brand Emami stepped into the competitive world of FMCG 50 years back, armed with just three products: Vanishing cream, talcum powder, and cold cream.

'PLI Has Been A Big Boost To Manufacturing'

'PLI Has Been A Big Boost To Manufacturing'

Rediff.com26 Sep 2024

'We can hope to see a lot of creation of jobs in the days to come.'

Indian pharma exports to Iran decline thanks to its lower rupee reserves

Indian pharma exports to Iran decline thanks to its lower rupee reserves

Rediff.com3 Oct 2023

India's pharmaceutical exports to Iran have been hit owing to depleting rupee reserves in the West Asian country because of India stopping the import of crude oil from it in 2019 following US sanctions. Pharmaceutical exports dropped 71.25 per cent in April-August this year over the same period last year. The data from the Pharmaceutical Exports Promotion Council (Pharmexcil) showed exports to Iran had declined 31.29 per cent in 2022-23 as against the previous financial year.

Electronics exports propelled by mobile show sharpest surge in top 10 club

Electronics exports propelled by mobile show sharpest surge in top 10 club

Rediff.com3 Jan 2024

Exports of electronics goods has risen by 24 per cent from April to November as compared with the same period in the last fiscal, the largest increase out of India's top 10 export categories. The increase has been propelled by mobile exports under the Production Linked Incentive (PLI) scheme and has pushed electronics up from sixth to fifth position in the top 10. A gap of $200 million separates electronics from occupying the fourth position, currently held by drugs and pharmaceuticals at $17.9 billion.

'Always Treat China With Caution'

'Always Treat China With Caution'

Rediff.com7 Nov 2024

'Given China's past behaviour and their territorial claims, should we be sceptical regarding China's willingness to adhere to these agreements fully? The answer is yes.' 'As Ronald Reagan famously said in the context of the SALT talks, 'Trust, but verify!' India should also do the same.' 'This has already begun with foot patrolling, drones, satellite imagery and so on. India's military deployment did mirror China's and will continue to do so in the future.'

Sun Pharma's growth pill: Specialising in specialty and scaling in India

Sun Pharma's growth pill: Specialising in specialty and scaling in India

Rediff.com25 Mar 2024

Traction for its specialty portfolio, a strong showing in the domestic market, and better regulatory compliance are positives for the country's largest pharmaceutical (pharma) company, Sun Pharmaceutical Industries. Given the triggers, some brokerages have increased their earnings per share estimates and target price for 2024-25 (FY25). This should sustain the momentum for the stock, which has been one of the major pharma gainers in 2023-24 (FY24), rising 57 per cent. It is currently trading at Rs 1,547 per share.

Pill Review: Impressive Riteish!

Pill Review: Impressive Riteish!

Rediff.com12 Jul 2024

Riteish Deshmukh makes this medical drama watchable! exclaims Namrata Thakker.

Budget may go vocal for higher local procurement

Budget may go vocal for higher local procurement

Rediff.com17 Jul 2024

To boost domestic manufacturing under the Make in India initiative and reduce dependency on imports, the government is expected to announce in the Budget an increase in the minimum local content requirement for public procurement, with certain sectors being granted exceptions. Currently, firms producing goods, services, or works with at least 50 per cent local content are classified as Class-I local suppliers and are preferred the most in government procurement.

Ready For Some Fantasy OTT?

Ready For Some Fantasy OTT?

Rediff.com12 Jul 2024

Fantasy and road trips rule OTT this week. Sukanya Verma gives you options to take your pick from.

Nifty expected to reach 24,500 level by Dec 2024

Nifty expected to reach 24,500 level by Dec 2024

Rediff.com28 May 2024

With an expected earnings growth of 15 per cent, benchmark index Nifty 50 may hit 24,500 level by December 2024 and move further to surpass the level of 26,500 by December 2025, Emkay Investment Managers said on Tuesday. The 50-share Nifty settled at 22,888.15 on Tuesday. In the previous day, it hit a new lifetime peak of 23,110.80.